Onward

The company develops spinal cord stimulation therapies, including the FDA-cleared ARC EX System, to improve hand sensation and strength in individuals with chronic cervical spinal cord injuries. Their technology portfolio includes non-invasive external stimulators, implantable systems, and brain-computer interfaces designed to restore movement and autonomic functions. These therapies are used by healthcare professionals in clinical settings and by patients for at-home rehabilitation exercises.